Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
| Company Type | Public |
| Employees Number | 78 |
| Date Founded | 1999 |
| Headquarters | Alachua, Florida |
| Number of Locations | 3 |
| Revenue | $24.2M |
| Net Income | US$ -21.30 million (FY JUN 30, 2018) |
| Market Capitalization | $117.7M |
| Total Assets | US$ 118.53 million (FY JUN 30, 2018) |
| Ticker | AGTC |
Applied Genetics Technologies Corporation received early financing of $27.0M on 2003-11-01.
| Series | Round size | Date |
|---|---|---|
| Series Unknown | $27M | 11/2003 |
| Series Unknown | $11.8M | 06/2009 |
| Grant | $1M | 09/2010 |
| Debt Financing | $750K | 05/2012 |
| Series B | $37.5M | 11/2012 |
| Post Ipo Equity | $32.5M | 02/2020 |
| Post Ipo Equity | $74.5M | 01/2021 |
| Investors | Security type |
|---|---|
| Intersouth Partners | Series Unknown |
| MedImmune Ventures Inc | Series Unknown |
| Skyline Ventures | Series Unknown |
| InterWest Partners | Series Unknown |
| Intersouth Partners | Series Unknown |
| MedImmune Ventures Inc | Series Unknown |
| InterWest Partners | Series Unknown |
| SR One | Series B |
| Intersouth Partners | Series B |
| MedImmune Ventures Inc | Series B |
| Osage University Partners | Series B |
| InterWest Partners | Series B |
| Alta Partners | Series B |
Applied Genetics Technologies Corporation's top competitor, Gilead Sciences, earned an annual revenue of $28.8B.
Applied Genetics Technologies Corporation's smallest competitor is Acambis with revenue of $10.0M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Seagen | $85,008 | $2.0B | 900 | - |
| Regeneron | $85,589 | $14.2B | 9,123 | 430 |
| Sanofi Genzyme | $84,495 | $4.6B | 12,000 | - |
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 653 |
| Baxter International | $54,368 | $10.6B | 48,000 | 235 |
| Nektar Therapeutics | $83,561 | $98.4M | 718 | - |
| Akorn | $62,397 | $682.4M | 2,227 | - |
| Danaher | $65,463 | $23.9B | 80,000 | 2,028 |
| Acambis | $75,102 | $10.0M | 350 | - |
| Novavax | $76,541 | $682.2M | 791 | 1 |
Zippia gives an in-depth look into the details of Applied Genetics Technologies Corporation, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Applied Genetics Technologies Corporation. The employee data is based on information from people who have self-reported their past or current employments at Applied Genetics Technologies Corporation. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Applied Genetics Technologies Corporation. The data presented on this page does not represent the view of Applied Genetics Technologies Corporation and its employees or that of Zippia.
Applied Genetics Technologies Corporation may also be known as or be related to APPLIED GENETIC TECHNOLOGIES CORP, Agtc, Applied Genetic Technologies, Applied Genetic Technologies Corp., Applied Genetic Technologies Corporation and Applied Genetics Technologies Corporation.